What does biotechnology — goodwill mean?

The value of intangible assets like brand and synergy recorded after acquiring other companies in this segment.

How do you interpret biotechnology — goodwill?

A high balance indicates significant past acquisition activity; a sudden decrease may signal an impairment charge due to underperforming acquisitions.

How does biotechnology — goodwill compare across companies?

High goodwill is common in M&A-heavy life science sectors, though investors monitor it closely for potential future write-downs.

Bio-Techne TECH Biotechnology — Goodwill

Discontinued — last reported Q4 '18

Similar metrics at other companies

ALife Sciences and Diagnostics Markets — Goodwill

$3B-0.1%

ALife Sciences and Applied Markets — Goodwill

$1.58B+0.3%

WAT

WATBiosciences — Goodwill

$3.8B—

IRBiopharma — Goodwill

$816.6M—

GTLSBiomedical — Goodwill

$24.5M+0.1%

BIO.BLife Science — Goodwill

——

Other financials

Income statement

See full

Revenue$311.4M-1.5%

Gross profit$208.3M-2.9%

Operating income$75.5M+95.0%

Net income$51.0M+126%

EPS (diluted)$0.32+129%

Balance sheet

See full

Cash & equivalents$209.8M+49.2%

Total debt$290.3M-31.4%

Total equity$2.1B+3.3%

Total assets$2.6B-3.5%

Cash flow

See full

Operating cash flow$86.7M+111%

CapEx$9.1M-10.2%

Free cash flow$77.6M+150%

Valuation

See full

Market cap$9.07B-11.8%

Enterprise value$9.15B-13.6%

P/E60.6×+13.6×

P/S7.5×-1.0×

Profitability

See full

Gross margin65%-0.8pp

Operating margin14.2%-7.9pp

Net margin10.9%-6.7pp

FCF margin22.3%+4.0pp

Returns & leverage

See full

Return on equity6.5%-3.9pp

Debt / equity0.1×-0.1×

Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Bio-Techne’s 10-K, filed August 27, 2018, on SEC EDGAR. View the filing →

Questions, answered.

What does biotechnology — goodwill mean?: The value of intangible assets like brand and synergy recorded after acquiring other companies in this segment.
How do you interpret biotechnology — goodwill?: A high balance indicates significant past acquisition activity; a sudden decrease may signal an impairment charge due to underperforming acquisitions.
How does biotechnology — goodwill compare across companies?: High goodwill is common in M&A-heavy life science sectors, though investors monitor it closely for potential future write-downs.